tirzepatide from eli lilly Shows Superiority in SURMOUNT-3 and 4 Eli Lilly is cracking down

When designing dose-escalation studies, establish three or four dosing tiers to identify threshold and saturation effects

By combining cutting-edge science with a patient-focused approach, AOD9604 is helping patients turn their weight loss dreams into reality

Some of the symptoms that indicate esophageal cancer are difficulty swallowing, unintentional weight loss, chest pain, indigestion, and coughing

In a large study involving 12,548 propensity matched type 2 diabetes patients from three U.S.-based insurance claims databases, addition of an SGLT2 inhibitor to background therapy with GLP-1 receptor agonist reduced the composite CV outcome by 24%, myocardial infraction by 29% and all-cause mortality by 32% (Dave CV, et al

hypothesize that the brain exposure levels were insufficient to activate the central MC system for weight loss

Bose KP et al